2C-I: Difference between revisions
From Pharmacopedia
More actions
| [unchecked revision] | [pending revision] |
MDElliottMD (talk | contribs) Auto-created stub |
MDElliottMD (talk | contribs) home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean) |
||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{MedTemplate | {{MedTemplate | ||
| generic | | generic = 2C-I | ||
| classes | | brand = | ||
| mechanism | | structure = | ||
| classes = Research material, Phenethylamine, Classic Psychedelic | |||
| mechanism = 5-HT2A agonist | |||
| uses = | |||
| starting_dose = | |||
| preparations = | |||
| fda_max = | |||
| routes = | |||
| onset = | |||
| duration = | |||
| halflife = | |||
| bioavailability = | |||
| pregnancy = | |||
| legal = | |||
| intro = | |||
| pharmacokinetics = | |||
| pharmacodynamics = | |||
| indications = | |||
| dosing = | |||
<titration slug="erowid-dose-oral" author="erowid-claude" | |||
title="Oral dose ladder (Erowid)"> | |||
Erowid's dosage documentation for oral 2C-I<ref name="erowid-2ci-dose"> | |||
Erowid. 2C-I Dosage. Erowid.org. | |||
https://www.erowid.org/chemicals/2ci/2ci_dose.shtml. | |||
Accessed 2026-05-25.</ref> reports the following tiers: | |||
* '''Threshold:''' 2-5 mg | |||
* '''Light:''' 5-15 mg | |||
* '''Common:''' 10-25 mg | |||
* '''Strong:''' 20-30 mg | |||
Heavy tier and timing data are not provided by Erowid. Erowid notes that | |||
2C-I is chemically distinct from the 2C-I-NBOMe compound despite similar | |||
naming. | |||
</titration> | |||
| effects = | |||
| interactions = <pharmaInteractions/> | |||
| pregnancy_details = | |||
| monitoring = | |||
| counseling = | |||
| anecdotes = | |||
| seealso = | |||
| references = | |||
}} | }} | ||
[[Category:Research chemicals]] | |||
[[Category:Phenethylamines]] | |||
[[Category:2C-x series]] | |||
[[Category:Classical Psychedelics (Serotonergic)]] | |||
[[Category:Psychedelics]] | |||